Tenders of Dak Gesundheit
Tenders of Dak Gesundheit
DAK Gesundheit Tender
Healthcare and Medicine
Germany
Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 Sgb V for the active ingredient Raltegravir, Atc J05ax08 for the period November 1st, 2023 - October 31st, 2025 (1004065 - Raltegravir, Atc J05ax08)
Closing Date5 Sep 2025
Tender AmountRefer Documents
DAK Gesundheit Tender
Others
Germany
Completion of a non-exclusive discount agreement According to § 130a para. 8 Sgb V To the active ingredient Fluticason + Vilanterol + Umeclidinium, Atc R03al08 For the period 01.07.2023 - 30.06.2025 (1003955 - Fluticason + Vilanterol + Umeclidinium, Atc R03al08)
Closing Date5 May 2025
Tender AmountRefer Documents
DAK Gesundheit Tender
Healthcare and Medicine
Germany
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Absatz 8 Sgb V Zum Wirkstoff Lisdexamfetamin, Atc N06ba12 (obg) Für Die Zeit 01.08.24 - 31.07.25 (zzgl. Verlängerungsoption 1x12 Monate)
Closing Date5 Jun 2026
Tender AmountEUR 1 (USD 1)
DAK Gesundheit Tender
Healthcare and Medicine
Germany
Conclusion of a non-exclusive discount agreement according to § 130a Para. 8 Sgb V for the active substance teriflunomide, Atc L04aa31 for the period 10/01/2023 - 09/30/2025 (1004033 - teriflunomide, Atc L04aa31)
Closing Date5 Aug 2025
Tender AmountRefer Documents
DAK Gesundheit Tender
Chemical Products
Germany
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient botulinum toxin type A (obo), ATC M03ax21 for the period 01.12.2024 - 30.11.2026
Closing Date5 Oct 2026
Tender AmountRefer Documents
11-20 of 342 active Tenders